The formation of herd immunity through vaccination is a key point in overcoming the
coronavirus disease 2019 (COVID-19) pandemic. To acquire herd immunity, a high …

Heterologous priming with the ChAdOx1 nCoV-19 vector vaccine followed by boosting with
a messenger RNA vaccine (BNT162b2 or mRNA-1273) is currently recommended in …

Knowledge on the immunogenicity of vector-based and mRNA-vaccines in solid organ
transplant recipients is limited. Therefore, SARS-CoV-2–specific T cells and antibodies were …

This review focuses on recent literature regarding the following clinical features of atopic
dermatitis (AD): diagnostic criteria, epidemiology and genetics, provocative factors …

Comparative analyses of the immunogenicity and reactogenicity of homologous and
heterologous SARS-CoV-2 vaccine-regimens will inform optimized vaccine strategies. Here …

Background School-level infection control measures in Germany during the early
Coronavirus Disease 2019 (COVID-19) pandemic differed across the 16 federal states and …

Background The aim of our study was to assess the impact the impact of gender and age on
reactogenicity to three COVID-19 vaccine products: Biontech/Pfizer (BNT162b2), Moderna …

Objective For an effective control of the SARS-CoV-2 pandemic with vaccines, most people
in a population need to be vaccinated. It is thus important to know how to inform the public …

Heterologous priming with the ChAdOx1-nCoV-19 vector-vaccine followed by boosting with
an mRNA-vaccine is currently recommended in Germany, although data on immunogenicity …

In the COVID-19 pandemic, children were considered to play a major role in SARS-CoV-2
transmission similar to influenza. Thus, mitigation measures have been focused on children …